VIS-101 Demonstrates Favorable Safety and Early Efficacy in Wet AMD
- March 23, 2026
Jenny Decker’s Journey: An Update
Imfinzi Achieves European Milestone: First Immunotherapy to Improve Survival in Early Gastric Cancer
New Pain Medicine Seeking FDA Approval
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Common HIV myths—and the facts that debunk them. Swipe to learn the truth about transmission, treatment, and living with HIV. Share to fight stigma and spread accurate information. Share your story with us here: bit.ly/4dV7gru
#hivawareness #HIV #endthestigma #PatientWorthy #shareyourstory
Jenny Decker's Journey: An Update bit.ly/40GsVhr. Read now at PatientWorthy.com
#PatientWorthy #charcotmarietoothdisease #CMT #PatientStory #jennydecker
Cure GRIN FoundationThe countdown to Virtual GRICON26 is ON!
We’ve built this year’s agenda to bridge the gap between lab research and your daily GRI life. Best of all? Registration is pay what you can! What’s in store:
🔬 Clinical Updates: Phase 3 breakthroughs from industry leaders.
🏠 Living GRI: IEP advocacy, behavior management, and adulthood transitions.
🚀 The Next Frontier: Deep dives into ASOs and genetic therapies.
🤝 Community: Dedicated networking for families and siblings.
Your Saturday, Your Way: Customize your day with breakout sessions that matter most to your journey. HUGE thanks to our Diamond Sponsor, GRIN Therapeutics!
🔗 Register & View Agenda: bit.ly/49nBinf
❤️ Support the Journey
Want to honor a loved one? Become a Family Sponsor! While GRICON is free to attend, your sponsorship ensures a world class experience and fuels the research collaborations our community needs.
✨ Become a Family Sponsor: bit.ly/4sPm3Ks
#GRICON26 #GRIfamily #CureGRIN #RareDisease
